1. Home
  2. NPCE vs CCAP Comparison

NPCE vs CCAP Comparison

Compare NPCE & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.48

Market Cap

432.3M

Sector

Health Care

ML Signal

HOLD

Logo Crescent Capital BDC Inc.

CCAP

Crescent Capital BDC Inc.

HOLD

Current Price

$13.36

Market Cap

456.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
CCAP
Founded
1997
2015
Country
United States
United States
Employees
N/A
250
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
432.3M
456.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NPCE
CCAP
Price
$15.48
$13.36
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$18.33
$15.93
AVG Volume (30 Days)
165.9K
192.5K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
12.53%
EPS Growth
29.03
N/A
EPS
N/A
N/A
Revenue
$99,986,000.00
N/A
Revenue This Year
$0.90
N/A
Revenue Next Year
$24.46
N/A
P/E Ratio
N/A
$14.18
Revenue Growth
25.13
N/A
52 Week Low
$7.56
$11.80
52 Week High
$18.97
$16.50

Technical Indicators

Market Signals
Indicator
NPCE
CCAP
Relative Strength Index (RSI) 62.07 60.65
Support Level $15.25 $13.18
Resistance Level $15.71 $13.48
Average True Range (ATR) 0.67 0.32
MACD 0.22 0.15
Stochastic Oscillator 91.26 92.60

Price Performance

Historical Comparison
NPCE
CCAP

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About CCAP Crescent Capital BDC Inc.

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Share on Social Networks: